ENTITY
SK Bioscience

SK Bioscience (302440 KS)

165
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
bullishSK Bioscience
26 Apr 2021 04:56

KOSPI200 Index Rebalance Preview: Review Period Almost Complete; Short Selling Commences in a Week

There could be up to 6 inclusions and 8 exclusions at the KOSPI200 index review in June. The inclusions could outperform the exclusions as short...

Logo
344 Views
Share
bullishSK Bioscience
25 Apr 2021 10:21

Why NPS Buys SK Bioscience Lately & Lurking Timing for KOSPI 200 Entry Event

This post investigates the recent buying of SK Bioscience by the Korea NPS and discusses the best lurking timing for KOSPI 200 entry event.

Logo
259 Views
Share
bullishLG Corp
23 Apr 2021 09:06

Korea Spin-Offs: Index Treatment

LG Corp, F&F and Ecopro will be suspended from trading on 29 April due to their spin offs. Passive funds will sell stock at the close on 28 April...

Logo
719 Views
Share
bullishSK Bioscience
19 Apr 2021 05:15

SK BioS Lockup Release Today: FO Drop Can Signal a Tight Supply for Passive Mirroring K200

SK Bioscience's lockup releases hit the market today. A substantial drop in FO can signal a tighter supply for passive funds, increasing the...

Logo
218 Views
Share
bullishSK Bioscience
13 Apr 2021 13:44

SK Bioscience K200 Entry: Potential Trades Reflecting SK Biopharm's Passive Inflow Pattern

This post finds the similarities between SK Biopharm and SK Bioscience concerning the passive money inflow pattern for the KOSPI 200 fast entry.

Logo
230 Views
Share
x